TB and HIV co-infection

Track09: TB and HIV co-infection

TB and HIV co-infection is when people have both HIV infection, and also either latent or active TB disease. When someone has both HIV and TB each disease speeds up the progress of the other. In addition to HIV infection speeding up the progression from latent to active TB, TB bacteria also accelerate the progress of HIV infection. TB also occurs earlier in the course of HIV infection than many other opportunistic infections. The risk of death in co-infected individuals is also twice that of HIV infected individuals without TB, even when CD4 cell count and antiretroviral therapy are taken into account.

Providing HIV antiretroviral therapy and anti TB drug treatment together

The provision of HIV antiretroviral therapy and anti TB drug treatment at the same time involves a number of potential difficulties including:

·         Cumulative drug toxicities

·         Drug – drug interactions

·         A high pill burden

·         The Immune Reconstitution Inflammatory Syndrome (IRIS)

  • Cumulative drug toxicities
  • Drug – drug interactions
  • A high pill burden
  • The Immune Reconstitution Inflammatory Syndrome (IRIS)

Related Conference of TB and HIV co-infection

March 17-18, 2025

54th World Congress on Microbiology

Berlin, Germany
July 28-29, 2025

17th International Virology Summit

Paris, France
August 25-26, 2025

6th International Conference on Molecular Microbiology

Singapore City, Singapore
September 22-23, 2025

13th World Congress and Expo on Applied Microbiology

Dubai, UAE

TB and HIV co-infection Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in